1. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) (2003) Guidance for Industry. Bioavailability and bioequivalence. Studies for orally adminsitered drug products—general considerations. CDER, Washington D.C.
2. Committee for Medicinal Products for Human Use (CHMP) (2010) Guideline on the investigation of bioequivalence. European Medicines Agency (EMA), London
3. WHO Expert Committee on Specifications for Pharmaceutical Preparations, World Health Organization (2006) Multisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability. WHO Technical Report Series 937. . WHO Press, Geneva, pp 347–390
4. Chow SC, Liu J (1997) Meta-analysis for bioequivalence review. J Biopharm Stat 7(1):97–111
5. Chow SC, Shao J (1999) Bioequivalence review for drug interchangeability. J Biopharm Stat 9(3):485–497